Hepion Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
HEPA
CUSIP
426897104
All holders as of
Q1 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 426897104 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Anson Funds Management LP 13G/A
4.9% 8/14/2025
Event 6/30/2025
S.H.N. Financial Investments Ltd. 13G/A 0% 8/14/2025
Event 8/14/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q1 34 7.15 M $5.55 M
2022 Q4 36 7.45 M $2.29 M
2022 Q3 36 7.15 M $3.61 M
2022 Q2 38 7.41 M $4.24 M
2022 Q1 43 7.56 M $9.74 M
2021 Q4 50 7.99 M $9.10 M
2021 Q3 47 7.80 M $11.9 M
2021 Q2 58 10.8 M $21.4 M
2021 Q1 52 7.97 M $14.7 M
2020 Q4 47 5.51 M $12.1 M
2020 Q3 23 268 k $832 k
2020 Q2 17 141 k $403 k
2020 Q1 15 209 k $368 k
2019 Q4 22 193 k $1.03 M
2019 Q3 17 156 k $377 k